These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2000599)

  • 1. [End of the drug monopoly in Norway?].
    Lunde PK
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):95-6. PubMed ID: 2000599
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward allocative efficiency in the prescription drug industry.
    Guell RC; Fischbaum M
    Milbank Q; 1995; 73(2):213-30. PubMed ID: 7776946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 4. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical patent legislation: a thoughtful and balanced approach.
    Erola J
    Clin Invest Med; 1996 Dec; 19(6):479-81. PubMed ID: 8959358
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 7. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 8. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug patent law reform and shortages.
    Myronuk LD; Meagher JB
    CMAJ; 1993 Nov; 149(9):1225. PubMed ID: 8221466
    [No Abstract]   [Full Text] [Related]  

  • 10. [Patents in the pharmaceutical field: history and development of the institution].
    Neri M
    Boll Chim Farm; 1995; 134(7):364-8. PubMed ID: 7546541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin consumption in Norway 1975-89. How much did the change to insulin 100 cost?].
    Berg C; Jervell J
    Tidsskr Nor Laegeforen; 1991 Feb; 111(4):471-3. PubMed ID: 2006490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746
    [No Abstract]   [Full Text] [Related]  

  • 14. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 15. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

  • 16. Building the proper foundation for genomics-based patents.
    Chahine KG
    Nat Biotechnol; 1998 Jul; 16(7):683-5. PubMed ID: 9661205
    [No Abstract]   [Full Text] [Related]  

  • 17. As a matter of scientific fact: applying the inherency doctrine in biotechnology.
    Moroz E; Schildkraut MJ
    Nat Biotechnol; 1997 Dec; 15(13):1403-4. PubMed ID: 9415895
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA's role in administering the Hatch-Waxman Act.
    Malkin BJ
    Food Drug Law J; 1999; 54(2):211-4. PubMed ID: 11758575
    [No Abstract]   [Full Text] [Related]  

  • 19. Patenting drug products: anticipating Hatch-Waxman issues during the claims drafting process.
    Mahn TG
    Food Drug Law J; 1999; 54(2):245-53. PubMed ID: 11758582
    [No Abstract]   [Full Text] [Related]  

  • 20. Limited lists of drugs: lessons from abroad.
    Smith T
    Br Med J (Clin Res Ed); 1985 Feb; 290(6467):532-4. PubMed ID: 3918661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.